Zyversa Therapeutics Inc. reports a Return on Equity (ROE) of 173.38%.

What is ZVSA's dividend yield?

Zyversa Therapeutics Inc. offers a dividend yield of 0.00%.

What is ZVSA's Quality Score?

Our AI rates ZVSA's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ZVSA?

Our AI Timing Score for ZVSA is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ZVSA belong to?

Zyversa Therapeutics Inc. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Zyversa Therapeutics Inc. (ZVSA) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

ZVSA AI Analysis Summary

Our AI summary for ZVSA: Zyversa Therapeutics Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of 173.38%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ZVSA

Zyversa Therapeutics Inc.

US:NASDAQ STOCK Healthcare >> Biotechnology News 57

USD 0.10

0.00 (3.40%) Day Change

Watchlist Portfolio Compare Chart

-84.96

D/E

173.4%

ROE

-3.3%

ROA

0.00%

Div Yield

ZYVERSA THERAPEUTICS INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.10 Price 0.00 (3.40%) Day Change	NEWS SCORE: 57

ZVSA, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...

No price data to display chart for the last 3-months of this stock

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: ROA is relatively low.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	57
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.10
PBV / Sector	N/A / 44,105.10
Earning Per Share	-2.52

PE / Sector	N/A / 19.37
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	1924.319120000000
Average 1W Daily Value	765.284500000000

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 97.23
NPM Average (%) / Sector	N/A / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-3.30 / 185,260.64
ROA Average (%) / Sector	-9,232.88 / 36,684.64
ROA Change Average (%) / Sector	3,419.13 / 422,221.42 GREAT
ROE (%) / Sector	173.38 / 243,761.81 GREAT
ROE Average (%) / Sector	-22,252.10 / 48,758.38
ROE Change Average (%) / Sector	26,110.09 / 424,967.86 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

Registration Details

Analyze Date	2026-08-06 08:00:58
Symbol	ZVSA
Name	ZYVERSA THERAPEUTICS INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	8.10 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1.00 / 9,702.21

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2200 N. Commerce Parkway, Weston, FL, United States, 33326

Phone: 754 231 1688

Website: https://www.zyversa.com

Sector: Healthcare >> Biotechnology

Description: ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100 a humanized monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of numerous inflammatory diseases, with cardiometabolic conditions associated with obesity as the lead. The company has a license agreement with L&F Research LLC, and InflamaCORE, LLC. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.